Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Mar 1;183(3):1083-92.
doi: 10.1084/jem.183.3.1083.

Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells

Affiliations

Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells

R Wen et al. J Exp Med. .

Abstract

Recent studies have shown that only a subset of major histocompatibility complex (MHC) class II molecules are able to present bacterial superantigens to T cells, leading to the suggestion that class-II associated peptides may influence superantigen presentation. Here, we have assessed the potential role of peptides on superantigen presentation by (a) analyzing the ability of superantigens to block peptide-specific T cell responses and (b) analyzing the ability of individual peptides to promote superantigen presentation on I-Ab-expressing T2 cells that have a quantitative defect in antigen processing. A series of peptides is described that specifically promote either toxic shock syndrome toxin (TSST) 1 or staphylococcal enterotoxin A (SEA) presentation. Whereas some peptides promoted the presentation of TSST-1 (almost 5,000-fold in the case of one peptide), other peptides promoted the presentation of SEA. These data demonstrate that MHC class II-associated peptides differentially influence the presentation of bacterial superantigens to T cells.

PubMed Disclaimer

References

    1. J Immunol. 1985 Jul;135(1):368-73 - PubMed
    1. Nature. 1993 Oct 14;365(6447):642-4 - PubMed
    1. J Immunol. 1987 Jul 15;139(2):629-38 - PubMed
    1. J Exp Med. 1988 May 1;167(5):1697-707 - PubMed
    1. J Immunol. 1989 Oct 15;143(8):2583-8 - PubMed

Publication types

MeSH terms